Purchase Order 75N91024P00539
- Not listed
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $21,740.40 firm fixed price purchase order to Agilent Technologies Inc. Customer Service And Sales Division for a SERVICE AGREEMENT FOR THE SEAHORSE XFE96 ANALYZER. The prime contractor, Agilent Technologies Inc., is a subsidiary of Agilent Technologies, Inc. Agilent Technologies Headquarters Division. Place of performance will be in Rockville, MD. The period of performance is from...
- The National Cancer Institute awarded a $22,622.75 firm fixed-price purchase order to Agilent Technologies Inc. on August 24, 2021, for the administrative de-obligation of unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a), with an ultimate completion date of August 23, 2022. The contract was performed at Agilent's Customer Service and Sales division location in Marshallton, Delaware, and utilized no set-aside designation. This action represents a...
- The U.S. National Cancer Institute awarded a firm-fixed-price purchase order contract worth $10,008.00 to Agilent Technologies Inc. Customer Service And Sales Division, a subsidiary of the global scientific instrumentation manufacturer Agilent Technologies, Inc. The contract is for the annual maintenance of two RTCA SP Analyzer & Station instruments during the period of November 7, 2024 to November 6, 2025. This award does not have a set-aside designation. Agilent Technologies, Inc. also...
- This is a federal contract award to Agilent Technologies Inc., a global leader in life sciences, diagnostics, and applied chemical markets. The contract, awarded by the National Cancer Institute (NCI), is for the delivery of scientific instruments, equipment, and services. The contract has a ceiling value of $211,329.40 and is a firm-fixed-price delivery order under the General Services Administration's Scientific Equipment and Services (FSS-66) schedule. The contract does not have a set-aside...
- This contract was awarded by the Department of Health and Human Services, National Institutes of Health, National Cancer Institute to Agilent Technologies Inc. to procure an Agilent Seahorse XFe96 Analyzer, a specialized instrument for measuring cellular metabolism. The contract has a firm fixed price of $164,253.00 and does not have a set-aside designation. The Agilent Seahorse XFe96 Analyzer will be used to support research activities at the National Cancer Institute. Agilent Technologies Inc....
- <p>The National Cancer Institute awarded a purchase order to Agilent Technologies Inc. on September 17, 2020, for one Agilent Seahorse XFE96 analyzer (64-bit) valued at $203,939.10, with completion targeted for September 24, 2020. Performance occurs in Marshallton, Delaware. The order was issued under firm fixed price terms with no set-aside designation, following a special notice solicitation posted August 6, 2020, with a due date of August 14, 2020.</p>
- This is a $22,092 firm fixed price purchase order contract awarded by the National Cancer Institute (NCI) to Agilent Technologies Inc. Customer Service and Sales Division. The contract is for a service agreement with a period of performance ending on July 31, 2025. Agilent Technologies Inc. is a subsidiary of the parent company Agilent Technologies, Inc., a global leader in life sciences, diagnostics, and applied chemical markets. The contract does not have a set-aside designation. Agilent has...
- Agilent Technologies Inc. Customer Service And Sales Division was awarded a $14,835.36 firm fixed price delivery order by the Department of Health and Human Services' National Institutes of Health National Cancer Institute for services in support of the agency's research programs. The delivery order was issued against Agilent Technologies Inc.'s Multiple Award Schedule contract vehicle and calls for the prime contractor to provide unspecified services to the National Cancer Institute through...
- The National Cancer Institute awarded a $40,960.08 delivery order to Agilent Technologies Inc. for laboratory equipment maintenance services. This order, issued April 1, 2026, with an ultimate completion date of March 31, 2027, represents a firm fixed-price contract with no set-aside designation, indicating full and open competition. The work will be performed at the NCI's Bethesda, Maryland location. Agilent Technologies, headquartered in Santa Clara, California, is a global leader in life...
- This is a $20,552.40 firm fixed-price purchase order awarded by the National Institute on Aging to Agilent Technologies Inc. for maintenance service on a Seahorse XFE96 Flux Analyzer, a specialized scientific instrument used in laboratory research. The contract has an ultimate completion date of August 31, 2026. Agilent Technologies Inc. is a global leader in life sciences and analytical instrumentation, providing advanced equipment and services to numerous federal agencies. This contract...
The National Cancer Institute (NCI), a civilian federal agency, awarded a $22,831.20 firm fixed price purchase order to Agilent Technologies Inc. for a service agreement to provide the Seahorse XFE96 Analyzer. This equipment is used for cellular bioenergetics research and will be delivered by July 31, 2025. Agilent, a global leader in life sciences instrumentation, has a long history of providing analytical equipment and services to various federal agencies through both prime and subcontracts. The award has no set-aside designation. Agilent also holds two active indefinite delivery/indefinite quantity contracts with the Department of Veterans Affairs and the Bureau of Alcohol, Tobacco, Firearms and Explosives for medical equipment and gas chromatography-mass spectrometry systems, respectively.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $22.8k | 6/27/24 |